Alto Neuroscience Stock Quote ANRO - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

14.18

Bid

Ask

Volume

22,746

13.94 Day's Range 14.17

12.7798 52 Week Range 24.00

Market Cap

379.671M

Previous Close

14.13

Open

13.94

Last Trade

2559

14.18

Last Trade Time

Financial Volume

$ 319,917

VWAP

14.0647

Average Volume (3m)

247,162

Shares Outstanding

26,794,000

Dividend Yield

PE Ratio

-10.46

Earnings Per Share (EPS)

-1.36

Revenue

Net Profit

-36.31M

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.altoneuroscience.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was $14.13. Over the last year, Alto Neuroscience shares have traded in a share price range of $ 12.7798 to $ 24.00.

Alto Neuroscience currently has 26,794,000 shares outstanding. The market capitalization of Alto Neuroscience is $379.67 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -10.46.

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

– ALTO-101 demonstrated a favorable pharmacokinetic and tolerability profile; novel transdermal formulation delivered significantly greater drug exposure and fewer adverse events typically...

Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the closing of its previously announced upsized initial public offering of 9,246,000 shares of common stock, which includes the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.69	5.11489992587	13.49	14.45	12.7798	97139	13.43987408	CS
4	-1.17	-7.62214983713	15.35	15.35	12.7798	111311	13.97096729	CS
12	-7.82	-35.5454545455	22	24	12.7798	247162	15.99809643	CS
26	-7.82	-35.5454545455	22	24	12.7798	247162	15.99809643	CS
52	-7.82	-35.5454545455	22	24	12.7798	247162	15.99809643	CS
156	-7.82	-35.5454545455	22	24	12.7798	247162	15.99809643	CS
260	-7.82	-35.5454545455	22	24	12.7798	247162	15.99809643	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M